tweenvest

Ab&B Bio-Tech CO., LTD. JS (SEHK: 2627)

Health Care · Biotechnology · CN

HK$29.32

-1.01% today · -28.3% 1Y

Public summary
A free snapshot of Ab&B Bio-Tech CO., LTD. JS, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Ab&B Bio-Tech CO., LTD. JS (SEHK: 2627) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.47B and employs 583 people.

Over the last twelve months the share price has lost 28.3%, trading between 28.88 and 73.00.

Tweenvest scores Ab&B Bio-Tech CO., LTD. JS across four factors: quality 27/100. Its strongest factor is quality.

2627 price history

Nov 21, 2025 · 40.26Weekly closes 29.32 – 57.30Mar 31, 2026 · 29.32

Key figures

Market cap
$1.47B
Revenue (TTM)
$45.19M
P/E
—
EPS
-0.76
Dividend yield
—
Beta (5Y)
—
52-week high
HK$73.00
52-week low
HK$28.88
Avg volume (3M)
—
Shares outstanding
393.44M
Employees
583
Next earnings
—

About Ab&B Bio-Tech CO., LTD. JS

Ab&B Bio-Tech Co., Ltd. engages in the research, development, manufacturing and commercialization of innovative and traditional vaccines. Its products include quadrivalent subunit influenza and lyophilized human rabies vaccines. The company was founded by You Cai An on October 28, 2015 and is headquartered in Taizhou, China.

ISIN
CNE1000071P9
Founded
2015
Listed since
Aug 11, 2025
Exchange
The Stock Exchange of Hong Kong Ltd.
Currency
HKD
CompanyMarket capPriceDay
Voronoi, Inc.KOSDAQ: A310210$1.51B₩111,000.00+1.19%
CanSino Biologics Inc.SEHK: 6185$1.50BHK$23.34-1.85%
AlvotechNasdaqGM: ALVO$1.50B$4.19-10.28%
Korsana Biosciences, Inc.NasdaqCM: KRSA$1.49B$32.68+3.25%
Biotest GmbH & Co. KGaAHMSE: BIO0$1.46B€33.40-0.60%
uniQure N.V.NasdaqGS: QURE$1.42B$20.30-2.24%
Absci CorporationNasdaqGS: ABSI$1.41B$8.18+7.92%
Oncolys BioPharma Inc.TSE: 4588$1.41B¥7,620.00-5.69%

Browse every Biotechnology company →